We conducted a real-world single-center retrospective cohort study looking at 67 patients with IBD on anti-TNF inhibitor therapy being actively followed at a New England IBD center to determine the prevalence of the HLADQA1*05 allele and to investigate the association between HLA status with loss of response and immunogenicity to anti-TNF therapy. The gene discussed is TNF; the disease is inflammatory bowel disease.